SeisWave specializes in cost-effective, cloud-based seismic data processing. Photo via Getty Images

An Austin-based climate accelerator announced its 2023 cohort, which includes a Houston cleantech startup.

StudioX named seven startups to its 2023 cohort, and SeisWave Corp., a seismic service company, will join the program that aims to help the world reach net-zero targets by 2050. The group comprises Studio X's third cohort since the company launched in 2020.

SeisWave specializes in cost-effective, cloud-based seismic data processing.

Other companies in the cohort include:

  • AI Technology & Systems: A NASA iTech company that provides compressed AI models and software
  • Austere Environmental: An environmental remediation solution that extracts chemical contaminants in soil, drill cuttings, and tailings
  • Economical Energy: A long-duration energy storage solution company
  • Flexergy: A developing highly efficient hydrogen gas compression, storage and distribution system
  • Onvol: An IoT power solutions tech company with applications in wind energy, transport, and mining
  • Project Geminae: A Midland, Texas-based AI-powered portfolio optimization platform advancing predictive modeling across industries

The companies will participate in a 16-week program and mentorship through the cohort, along with investment opportunities.

“Our accelerator program helps to close that gap through bringing together an engaged community that grows these companies at a faster rate, ultimately driving innovation, and helping to evolve global energy solutions,” Jeff Allyn, CEO of Studio X, says in a statement.

Studio X is fully-owned and incubated by Shell and aims to "break down the silos of traditional R&D," according to its website. Click here to view some of the accelerator's past participants.

The company will host an Accelerator Showcase Event Friday, Nov. 10, where companies will pitch their concepts and offer a Q&A session. Register here.

Another Shell-backed accelerator announced its cohort earlier this week. In partnership with Greentown Labs, the organizations announced the cohort for Greentown Go Make 2023, which aims to accelerate partnerships between startups and corporations to advance carbon utilization, storage, and traceability solutions. The cohort includes six companies from around the world, from the Netherlands and Canada to Massachusetts and Washington state.

Additionally, The Goodwill Clean Tech Accelerator will launch in Houston next year to help advance clean tech jobs. According to Accenture and Goodwill, which are partners in the accelerator, said it plans to grow the program to 20 cities in the next seven years and train an estimated 7,000 job seekers.

———

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”